This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Pistacia lentiscus var. chia
Greek Chios island exclusive resin with EU PDO protection for H. pylori.
Greek Chios island exclusive resin with EU PDO protection for H. pylori. Key active compounds include Masticadienonic acid, Isomasticadienonic acid, Oleanonic acid.
Masticadienonic acid, along with Isomasticadienonic acid and Oleanonic acid, are the primary bioactive compounds in Chios Mastic v2. The specific pharmacological pathways require further study, though traditional use supports its efficacy.
Anti-H. pylori
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Gastroprotective
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Oral health
Gastric ulcers
Based on traditional use; clinical evidence limited
Bad breath
Based on traditional use; clinical evidence limited
Dental health
Based on traditional use; clinical evidence limited
Digestive problems
Based on traditional use; clinical evidence limited
Found an error or have a correction for Chios Mastic v2?
Report an Issue →